
News|Articles|July 1, 2004
Statin therapy should be considered for all patients with type 2 diabetes
A recent study found that atorvastatin at its starting dosage reduces the risk of a first major cardiovascular event in patients with type 2 diabetes, said Helen Colhoun, MD, at the 64th scientific sessions of the American Diabetes Association (ADA) in Orlando.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
2
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
3
Insights from the AMCP Nexus 2025 Meeting
4
The Shift in Star Ratings That Health Plans Can't Ignore
5
















































